These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6112772)

  • 1. Nongenetic factors affecting human platelet monoamine oxidase [proceedings].
    Friedhoff AJ; Miller JC
    Psychopharmacol Bull; 1981 Jan; 17(1):101-3. PubMed ID: 6112772
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings].
    Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet monoamine oxidase as a function of nongenetic factors.
    Friedhoff AJ; Miller JC
    Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 8. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S; Yamane H; Tani N
    Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 11. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density.
    Friedhoff AJ; Miller JC; Karpatkin S
    Blood; 1978 Feb; 51(2):317-23. PubMed ID: 563748
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 20. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.